Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Relative Frequency of Early Virologic Response to Treatment With a Combination of Conventional Interferon and Ribavirin in Patients With Chronic Hepatitis C



Rostami M1 ; Sabaghi B2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Infectious Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. School of Medicine And Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2012

Abstract

Background: Chronic hepatitis C virus infection is the most common infectious disease among intravenous drug abusers. We tried to determine the effects of combination therapy using conventional interferon and ribavirin during 12 weeks. Methods: In this descriptive analytical study in 2011, 25 patients with chronic hepatitis C who referred to Infectious Diseases Research Center (Isfahan, Iran) were treated with conventional interferon plus ribavirin. After 12 weeks, early virologic response (EVR) was determined using polymerase chain reaction (PCR). The collected data was analyzed in SPSS. Findings: The mean virologic load in PCR was 3549878 ± 6139188. After 12 weeks, the virologic load decreased more than 2log in 5 patients (20%) and less than 2log in 1 patient (4%). The reductions were undetectable in 19 patients (76%). Conclusion: Treatment with conventional interferon plus ribavirin was effective in this shortterm study.
Related Docs
View other Related Docs
1. Efficacy of Triple Therapy With Interferon Alpha-2B, Ribavirin and Amantadine in the Treatment of Naive Patients With Chronic Hepatitis C, Journal of Research in Medical Sciences (2007)
2. A Multicenter Study to Evaluate the Safety and Efficacy of Heberon (Interferon Alfa-2B) in Combination With Ribavirin for the Treatment of Chronic Hepatitis C in Iran, Medical Journal of the Islamic Republic of Iran (2005)
3. Sd1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-Cost, Fixed-Dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase Iii Clinical Trial, Clinical Infectious Diseases (2020)
4. The Interleukin 28B Gene Polymorphism, Rs8099917, in Patients With Chronic Hepatitis C and Response to the Treatment With Pegylated Interferon and Ribavirin, Journal of Research in Medical Sciences (2019)
5. Efficacy of Interferon Alpha-2B With or Without Ribavirin in Thalassemia Major Patients With Chronic Hepatitis C Virus Infection: A Randomized, Double Blind, Controlled, Parallel Group Trial, Journal of Research in Medical Sciences (2010)
6. Interleukin-28B (Rs12979860) Gene Variation and Treatment Outcome After Peginterferon Plus Ribavirin Therapy in Patients With Genotype 1 of Hepatitis C Virus, Journal of Research in Medical Sciences (2014)
7. Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline, Hepatitis Monthly (2016)
8. Hepatitis C Screening in Isfahan Drop in Centers: An Experience Description, Journal of Isfahan Medical School (2011)
Experts (# of related papers)
View all Related Experts
Behrooz Ataei (13)
Zary Nokhodian (11)
Other Related Docs
9. Hepatitis C Among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors, International Journal of Preventive Medicine (2012)
10. Hepatitis C Screening in Intravenous Drug Users Under Treatment With Methadone: An Action Reserch Study, Journal of Isfahan Medical School (2011)
11. Positive Hepatitis C Virus Antibody in Cases With History of Intravenous Drug Abuse Via Community Announcement: A Useful Experience, Journal of Isfahan Medical School (2011)
12. The Combination of Sofosbuvir and Daclatasvir Is Effective and Safe in Treating Patients With Hepatitis C and Severe Renal Impairment, Journal of Gastroenterology and Hepatology (Australia) (2020)
13. Statin Efficacy in the Treatment of Hepatitis C Genotype I, Journal of Research in Medical Sciences (2014)
14. A Mini-Review on Sofosbuvir and Daclatasvir Treatment in Coronavirus Disease 2019, New Microbes and New Infections (2021)
15. The Relationship Between Hcv-Ns5a Gene Mutations and Resistance to Combination Therapy in Patients With Hcv-Genotype 1-B, Reports of Biochemistry and Molecular Biology (2021)
16. Seroprevalence of Hepatitis a Virus in Patients With Chronic Hepatitis B or C in Isfahan Province, Iran, Journal of Isfahan Medical School (2012)
17. Amazing Results With Hydroxyurea Therapy in Chronic Hepatitis B: A Preliminary Report, Hepatitis Monthly (2010)
18. Hepatitis C Screening in Intravenuos Drug Users in Golpayegan, Isfahan Through Community Announcement: Pilot Study, Journal of Isfahan Medical School (2011)
19. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran, Hepatitis Monthly (2017)
20. Hepatitis C Virus Genotype Frequency in Isfahan Province of Iran: A Descriptive Cross-Sectional Study, Virology Journal (2010)
21. Identification of Patients With Hepatitis C Virus Infection in Persons With Background of Intravenous Drug Use: The First Community Announcementbased Study From Iran, International Journal of Preventive Medicine (2012)
22. Erratum: Sd1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-Cost Fixed-Dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase Iii Clinical Trial (Clin Infect Dis (2020) 70:10 (2206-2212) Doi: 10.1093/Cid/Ciz628), Clinical Infectious Diseases (2021)
23. Effects of Silybum Marianum on Patients With Chronic Hepatitis C, Journal of Research in Medical Sciences (2011)
24. Seroprevalence of Hepatitis a in Patients With Chronic Hepatitis C in Isfahan Province, International Journal of Preventive Medicine (2012)
25. Seroprevalence and Risk Factors of Hepatitis C Virus Among Juveniles in Correctional Center in Isfahan, Iran, International Journal of Preventive Medicine (2012)
26. Hepatitis C in Intravenous Drug Users: Seroprevalence and Risk Factors, Journal of Isfahan Medical School (2011)
27. The Relationship Between Hcv-Ns5a Gene Mutations and Resistance to Combination Therapy in Patients With Hcv- Genotype 1-B, Reports of Biochemistry and Molecular Biology (2021)
28. Anti-Hepatitis E Antibody in Hemodialysis Patients in Isfahan, Iran: Prevalence and Risk Factors, Hepatitis Monthly (2015)
29. Hepatic Steatosis in Iranian Patients With Chronic Hepatitis C, Medical Principles and Practice (2008)
30. The Experience of Hepatitis C Screening Among Prison Inmates With Drug Injection History, Journal of Isfahan Medical School (2011)